PMI’s (NYSEAMERICAN:PMI – Get Free Report) lock-up period is set to expire on Wednesday, February 25th. PMI had issued 4,250,000 shares in its initial public offering on August 29th. The total size of the offering was $17,000,000 based on an initial share price of $4.00. After the end of PMI’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.
PMI Stock Performance
PMI stock opened at $1.26 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.94 and a current ratio of 2.16. PMI has a 12-month low of $1.20 and a 12-month high of $13.68.
PMI News Summary
Here are the key news stories impacting PMI this week:
- Neutral Sentiment: Recent macro PMI/economic reads (likely market‑wide context but not specific to Picard Medical): Euro‑zone business activity improved in February as manufacturing bounced back. Euro zone business activity improved in February as manufacturing bounced back, PMI shows
- Neutral Sentiment: US composite PMI slipped in February, trailing consensus — a macro datapoint that may influence broader market flows but does not directly affect Picard Medical’s fundamentals. US composite PMI slips in February, trailing consensus
- Negative Sentiment: Multiple law firms have filed or announced class‑action suits and are soliciting lead‑plaintiff motions on behalf of investors who bought PMI between Sept. 2 and Oct. 31, 2025 — with April 3 or April 13, 2026 deadlines to act. These notices increase legal risk, could spur selling by shareholders, raise potential future liabilities, and deter buyers until the litigation clears. Representative firm notices include Rosen Law Firm, Robbins LLP, Schall Law Firm, Faruqi & Faruqi, Pomerantz, Levi & Korsinsky, Bronstein Gewirtz & Grossman, Portnoy Law Firm, The Gross Law Firm, Wolf Haldenstein, and others. ROSEN, A HIGHY RANKED LAW FIRM, Encourages Picard Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PMI PMI CLASS ACTION: Picard Medical, Inc. Investors with Significant Losses Should Contact Robbins LLP for Information About Recovering Their Losses PMI Investors Have Opportunity to Lead Picard Medical, Inc Securities Fraud Lawsuit with the Schall Law Firm
About PMI
Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.
Read More
- Five stocks we like better than PMI
- Elon Musk already made me a “wealthy man”
- America’s 1776 happening again
- [How To] Invest Pre-IPO In SpaceX With $100!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for PMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMI and related companies with MarketBeat.com's FREE daily email newsletter.
